We are live on ! Find out more
KURA icon

Kura Oncology
KURA

116 hedge funds and large institutions have $529M invested in Kura Oncology in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 54 increasing their positions, 27 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 27

90% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 10

8% more funds holding

Funds holding: 107 → 116 (+9)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

2% less capital invested

Capital invested by funds: $541M → $529M (-$11.5M)

8.96% less ownership

Funds ownership: 88.57% → 79.61% (-9%)

30% less call options, than puts

Call options by funds: $263K | Put options by funds: $375K

Holders
116
Holders Change
+9
Holders Change %
+8.41%
% of All Funds
2.65%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
19
Increased
54
Reduced
27
Closed
10
Calls
$263K
Puts
$375K
Net Calls
-$112K
Net Calls Change
+$2.04M

Top Buyers

1
EAM
Eagle Asset Management
Florida
+$13.5M
2
CTA
Carillon Tower Advisers
Florida
+$11M
3
BlackRock
BlackRock
New York
+$7.55M
4
KCM
Kennedy Capital Management
Missouri
+$5.53M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.7M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$20.7M
2
GPP
Great Point Partners
Connecticut
-$9.74M
3
SFM
Sphera Funds Management
Israel
-$6.41M
4
Invesco
Invesco
Georgia
-$3.17M
5
SCM
Sio Capital Management
New York
-$2.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
51
TIAA CREF Investment Management
New York
$729K -$109K -5,699 -12%
GHCM
52
Glen Harbor Capital Management
California
$655K +$31.9K +1,666 +5%
Goldman Sachs
53
Goldman Sachs
New York
$637K -$11.1K -577 -2%
CC
54
Caxton Corporation
New Jersey
$607K +$351K +18,293 +111%
MCIM
55
Meadow Creek Investment Management
Georgia
$539K +$26.3K +1,372 +5%
B
56
Bailard
California
$525K – – –
PPCM
57
Pillar Pacific Capital Management
California
$510K – – –
Citadel Advisors
58
Citadel Advisors
Florida
$487K +$40.7K +2,123 +8%
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
$483K – – –
State of Wisconsin Investment Board
60
State of Wisconsin Investment Board
Wisconsin
$453K +$286K +14,900 +135%
RJA
61
Raymond James & Associates
Florida
$449K +$492K +25,638 New
VEA
62
Virtus ETF Advisers
New York
$445K -$349K -18,195 -42%
EP
63
Elkfork Partners
Oregon
$424K +$20.7K +1,078 +5%
RhumbLine Advisers
64
RhumbLine Advisers
Massachusetts
$408K -$5.94K -310 -1%
AllianceBernstein
65
AllianceBernstein
Tennessee
$397K +$113K +5,900 +35%
SCA
66
Secor Capital Advisors
New York
$337K +$369K +19,242 New
Two Sigma Investments
67
Two Sigma Investments
New York
$333K +$365K +19,027 New
ProShare Advisors
68
ProShare Advisors
Maryland
$332K +$31.8K +1,661 +10%
AIG
69
American International Group
New York
$329K +$49.5K +2,583 +16%
WG
70
Winton Group
United Kingdom
$325K +$356K +18,592 New
AQR Capital Management
71
AQR Capital Management
Connecticut
$321K +$13.5K +703 +4%
CS
72
Credit Suisse
Switzerland
$318K +$93.3K +4,869 +37%
TAM
73
Tyers Asset Management
Texas
$308K +$15K +784 +5%
BTS
74
BB&T Securities
Virginia
$287K +$8.15K +425 +3%
SIM
75
Spark Investment Management
New York
$285K +$74.8K +3,900 +31%
1 2
3
4 5

KURA Hedge Fund Activity: Q3 2018 in Review

116 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q3 2018, worth a combined $529M — down 2.1% from $541M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new KURA positions and 10 closed out — a net gain of 9 holders — while 54 added to existing stakes and 27 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $13.5M. The largest seller was Fidelity Investments, cutting an estimated $20.7M.

  • 116 institutional investors held Kura Oncology (KURA) as of Q3 2018, up from 107 in Q2 2018.
  • Funds reported $529M of Kura Oncology stock for Q3 2018, down 2.1% quarter-over-quarter.
  • 19 funds opened new Kura Oncology positions in Q3 2018 and 10 closed out, a net change of +9 holders.
  • The largest Kura Oncology buyer in Q3 2018 was Eagle Asset Management, an estimated $13.5M added.
  • The largest Kura Oncology seller in Q3 2018 was Fidelity Investments, an estimated $20.7M sold.

Based on aggregated 13F filings for Q3 2018.